CU
CURLF.US Curaleaf Holdings Inc
- Market cap
- USD 2.08B
- P/E
- -
- P/B
- 2.52x
- ROE
- 7.8%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is CURLF.US undervalued?
Graham numberThe Graham number of Curaleaf Holdings Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Curaleaf Holdings Inc fundamental analysis
No fundamental analysis for Curaleaf Holdings Inc yet.
Curaleaf Holdings Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Curaleaf Holdings Inc
Curaleaf Holdings, Inc. engages in the retail and wholesale of cannabis products in the United States and internationally. The company operates licensed cultivation; and pharma-grade cannabis processing and manufacturing facilities. It also supplies cannabis on a wholesale basis to Australia, New Zealand, the United Kingdom and various European countries, including Germany, Italy, Poland, the Czech Republic, Switzerland, Sweden and Norway. In addition, the company operates a…
Full company profileCuraleaf Holdings Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Curaleaf Holdings Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 0.00 | 19.3M | 77.1M | 221M | 627M | 1.21B | 1.28B | 1.35B | 1.33B | 1.27B | 1.36B |
| Gross Profit | 3.71M | 15.6M | 46.3M | 142M | 391M | 688M | 626M | 614M | 641M | 631M | 664M |
| Operating Income | -118K | -6.55M | -28.7M | -27.7M | 63.7M | 176M | 65.0M | 42.9M | 24.7M | 25.5M | 10.6M |
| EBITDA | - | 1.34M | -40.3M | 16.2M | 180M | 288M | 168M | 188M | 235M | 239M | 223M |
| Net Income | -118K | -2.82M | -56.5M | -67.2M | -61.7M | -102M | -370M | -281M | -238M | -273M | 66.1M |
| EPS | - | -2.42 | -0.12 | -0.14 | -0.09 | -0.14 | -0.52 | -0.38 | -0.32 | -0.35 | 0.25 |
| Balance Sheet | |||||||||||
| Total Assets | 47.7K | 152M | 570M | 737M | 2.39B | 3.26B | 3.40B | 3.10B | 2.95B | 2.85B | 2.79B |
| Total Liabilities | 11.5K | 46.8M | 134M | 333M | 1.01B | 1.45B | 2.00B | 1.93B | 1.96B | 2.01B | 1.95B |
| Shareholders' Equity | 36.2K | 105M | 436M | 403M | 1.38B | 1.81B | 1.40B | 1.17B | 993M | 840M | 847M |
| Cash & Short-term Investments | 0.00 | 0.00 | 0.00 | 42.3M | 73.5M | 299M | 163M | 91.8M | 93.0M | 89.2M | 92.4M |
| Cash Flow | |||||||||||
| Operating Cash Flow | -2.05M | -7.72M | -33.1M | -38.3M | 12.4M | -34.0M | 46.4M | 164M | 164M | 138M | 95.1M |
| Capital Expenditure | 589.99 | 10.6M | 44.9M | 82.1M | 126M | 172M | 135M | 97.4M | 97.4M | 64.6M | 71.3M |
| Free Cash Flow | - | -18.5M | -79.0M | -120M | -114M | -206M | -88.2M | 66.2M | 66.2M | 73.1M | 23.8M |
| Ratios | |||||||||||
| ROE | -326.7% | -2.7% | -13.0% | -16.7% | -4.5% | -5.6% | -26.4% | -24.0% | -24.0% | -32.5% | 7.8% |
| ROA | -247.8% | -1.9% | -9.9% | -9.1% | -2.6% | -3.1% | -10.9% | -9.1% | -8.1% | -9.6% | 2.4% |
| Net Profit Margin | - | -14.6% | -73.3% | -30.4% | -9.9% | -8.4% | -29.0% | -20.9% | -17.8% | -21.6% | 4.9% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Curaleaf Holdings Inc dividends
Curaleaf Holdings Inc has not paid dividends in the last 9 fiscal years.
Last stock split: 1:3 on Jun 5, 2026.
Who owns Curaleaf Holdings Inc
- Insiders 25.77%
- Institutions 9.68%
- Public & others 64.55%
- Shares outstanding 234M
- Free float 215M
Curaleaf Holdings Inc company profile
- Company name
- Curaleaf Holdings Inc
- Ticker
- CURLF.US
- ISIN
- CA23126M1023
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Pharmaceuticals
- Employees
- 5,554
- Fiscal year end
- December
- Address
- 290 Harbor Drive, Stamford, CT, United States, 06902
- Phone
- 781 451 0159
- Website
- curaleaf.com
About Curaleaf Holdings Inc
Curaleaf Holdings, Inc. engages in the retail and wholesale of cannabis products in the United States and internationally. The company operates licensed cultivation; and pharma-grade cannabis processing and manufacturing facilities. It also supplies cannabis on a wholesale basis to Australia, New Zealand, the United Kingdom and various European countries, including Germany, Italy, Poland, the Czech Republic, Switzerland, Sweden and Norway. In addition, the company operates a medical cannabis clinic and holds a pharmacy license. It serves the medical and adult-use cannabis markets through retail and wholesale channels. The company is based in Stamford, Connecticut.
Curaleaf Holdings Inc management
10- Mr. Boris Alexis JordanCEO & Chairman · born 1966
- Mr. Joseph F. LusardiExecutive Vice-Chairman · born 1975
- Mr. Rahul PintoPresident
- Mr. Edward KremerChief Financial Officer · born 1972
- Mr. Peter Laurence Clateman J.D.Chief Legal Officer · born 1968
- Mr. Camilo Russi LyonChief Investment Officer
- Mr. Daniel MickelsonChief Accounting Officer
- Mr. Scott BaughmanChief Technology Officer
- Mr. Matthew S. DarinSpecial Advisor
- Ms. Helen ChenSenior Vice President of Digital